相关实验视频

Updated: Jan 12, 2026

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Published on: June 2, 2022

氨酸合成酶2功能障碍加剧了老鼠的弹性酶诱导的中性恋呼吸道炎症和肺气

Kengo Nishino¹, Takumi Kiwamoto¹, Masashi Matsuyama¹

¹Department of Pulmonary Medicine, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.

Frontiers in immunology

|November 3, 2025

概括

氨酸合成酶2 (HAS2) 功能障碍使慢性阻塞性肺病 (COPD) 和小鼠肺气恶化. 这突出了HAS2的重要性.

科学领域:

肺部医学肺部医学
炎症研究炎症研究
分子生物学分子生物学

背景情况:

慢性阻塞性肺病 (COPD) 是一种渐进的炎症性肺病,通常是由环境暴露引起的.
氨酸合成酶2 (HAS2) 产生抗炎性高分子量氨酸 (HMW-HA).
之前的研究表明,HAS2功能障碍可能会使COPD恶化,但其在肺气进展中的具体作用尚未完全理解.

研究的目的:

为了研究HAS2功能障碍对呼吸道炎症和肺气发育在COPD小鼠模型的影响.
为了确定是否降低了HAS2活性加剧了COPD相关的肺病理.

主要方法:

使用猪胰腺弹性酶 (PPE) 诱导的COPD模型在异性缺陷 (Has2) 鼠和野生型 (WT) littermates.
通过支气管膜洗液分析评估呼吸道炎症 (细胞和中性粒细胞计数).
使用组织学分析 (平均线性截止) 和测量肺G-CSF和TGF-β水平,量化了肺气的严重程度. 进行RNA测序和基因本体学分析.

主要成果:

与WT小鼠相比,Has2+/-小鼠在支气管支气管洗液后的PPE管理中显示出明显增加的总细胞和中性粒细胞数量.
组织学分析显示,在Has2^+/-小鼠中,肺气的恶化,由较高的平均线性截止值表明.
用PPE刺激的Has2+/-小鼠显示G-CSF水平升高,肺部TGF-β减弱,RNA测序显示TGF-β受体信号通路的激活负调节.

结论:

在小鼠模型中,HAS2功能障碍加剧了中性友气道炎症和肺气,强调了它的保护作用.
在HAS2缺乏的小鼠中,恶化的炎症反应可能涉及G-CSF和TGF-β信号通路.
这些发现表明了针对COPD管理的HAS2的潜在治疗策略.

关键词:

在G-CSF中使用.在HAS2中,它是HAS2.在TGF-β1中.慢性阻塞性肺病慢性阻塞性肺病突发性质炎症是什么意思作为一个中性恋者.

更多相关视频

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins

Published on: June 14, 2016

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples

Published on: May 21, 2021

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.